Company History

Our company roots go back to 1923, but our modern focus is on attending to our clients' needs and expectations.
Since 1923 Isolation and purification of insulin from bovine pancreas
Since 1930 Isolation and purification of insulin from porcine pancreas
From 1930 to 1963 Isolation and purification of gonadotropins Prolan A (Follicle Stimulating Hormone, FSH) and Prolan B (Lutenising Hormone, LH) from pituitary glands
From 1931 to 1966 Isolation and purification of Human Chorionic Gonadotropin (HCG) from human placenta
Since 1942 Isolation and purification of Adreno Corticotropic Hormone (ACTH) from pituitary glands
Since 1948 Isolation and purification of heparin from bovine lung
Since 1955 Isolation and purification of heparin from porcine mucosa
Since 1963 Isolation and purification of Human Menopausal Gonadotropin (HMG) from urine of menopausal women
Since 1966 Isolation and purification of Human Chorionic Gonadotropin (HCG) from urine of pregnant women
Since 1987 Isolation and purification of Hyaluronic Acid from rooster combs
Since 1995 Production of recombinant Follicle Stimulating Hormone (FSH)
1995 Corning BioPro (now Diosynth RTP Inc.) founded as part of Corning Pharmaceutical Services
1995 Groundbreaking on 109,000ft.2 (10,320 m2) dedicated multi-product cGMP production facility in RTP, North Carolina, USA
1996 Official opening of Diosynth's new campus in Oss, the Netherlands
1996 Corning Pharmaceutical Services spun-off as Covance, Inc. and Covance Biotechnology Services Inc. founded as a subsidiary
1997 First clinical product shipped from the RTP facility, North Carolina, USA
1998 First FDA inspection of Diosynth's recombinant protein facilities in Oss, the Netherlands, leads to marketed product
1999 Diosynth begins process development of recombinant insulin
2000 Formal opening of state-of-the-art cGMP downstream processing facility and official start of the upstream facility expansion in Oss, the Netherlands
2001 May - First FDA inspection at RTP, North Carolina, USA, facility
2001 June - Akzo Nobel Inc. acquires Covance Biotechnology Services Inc., forming Diosynth RTP Inc.
2001 October - Announcement of additional investment in upstream facility in Oss, the Netherlands
2002 October - Research Triangle Park (RTP), North Carolina, USA, facility hosts EMEA inspection
2003 June – Diosynth Biotechnology signs multi-year contract with Pfizer Inc to produce commercial product
2006 May – Diosynth Biotechnology incorporates a novel cell line development technology into its portfolio of offerings
2007 November – Diosynth Biotechnology becomes a part of Schering-Plough Corporation

See also